RANDOMIZED PHASE II/III TRIAL OF PROPHYLACTIC CRANIAL IRRADIATION WITH OR WITHOUT HIPPOCAMPAL AVOIDANCE FOR SMALL CELL LUNG CANCER

Protocol: 
AAAQ8097
Phase: 
II/III

RANDOMIZED PHASE II/III TRIAL OF PROPHYLACTIC CRANIAL IRRADIATION WITH OR WITHOUT HIPPOCAMPAL AVOIDANCE FOR SMALL CELL LUNG CANCER

Are you Eligible? (Inclusion Criteria)

- Subject must be 18 years of age or older
- Subject must have Small Cell Lung Cancer
- Subject must undergo protocol-specific MRI scans
- Subject must not have Central Nervous System metastases

Specialty Area(s)

Trial Location

Herbert Irving Comprehensive Cancer Center
161 Fort Washington Ave.
Herbert Irving Pavilion
New York, NY 10032
United States